Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_Rx" table for query
on "022264."
| Active Ingredient: |
PALIPERIDONE PALMITATE |
| Dosage Form;Route: |
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR |
| Proprietary Name: |
INVEGA SUSTENNA |
| Applicant: |
JANSSEN PHARMS |
| Strength: |
39MG/0.25ML (39MG/0.25ML) |
| Application Number: |
N022264 |
| Product Number: |
001 |
| Approval Date: |
Jul 31, 2009 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
PALIPERIDONE PALMITATE |
| Dosage Form;Route: |
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR |
| Proprietary Name: |
INVEGA SUSTENNA |
| Applicant: |
JANSSEN PHARMS |
| Strength: |
78MG/0.5ML (78MG/0.5ML) |
| Application Number: |
N022264 |
| Product Number: |
002 |
| Approval Date: |
Jul 31, 2009 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
PALIPERIDONE PALMITATE |
| Dosage Form;Route: |
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR |
| Proprietary Name: |
INVEGA SUSTENNA |
| Applicant: |
JANSSEN PHARMS |
| Strength: |
117MG/0.75ML (117MG/0.75ML) |
| Application Number: |
N022264 |
| Product Number: |
003 |
| Approval Date: |
Jul 31, 2009 |
| Reference Listed Drug |
Yes |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
PALIPERIDONE PALMITATE |
| Dosage Form;Route: |
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR |
| Proprietary Name: |
INVEGA SUSTENNA |
| Applicant: |
JANSSEN PHARMS |
| Strength: |
156MG/ML (156MG/ML) |
| Application Number: |
N022264 |
| Product Number: |
004 |
| Approval Date: |
Jul 31, 2009 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
PALIPERIDONE PALMITATE |
| Dosage Form;Route: |
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR |
| Proprietary Name: |
INVEGA SUSTENNA |
| Applicant: |
JANSSEN PHARMS |
| Strength: |
234MG/1.5ML (156MG/ML) |
| Application Number: |
N022264 |
| Product Number: |
005 |
| Approval Date: |
Jul 31, 2009 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
Return to Electronic Orange Book Home Page
|
FDA/Center for Drug Evaluation and Research
|
|
Office of Generic Drugs
|
|
Division of Labeling and Program Support
|
|
Update Frequency: |
|
Orange Book Data - Monthly
|
|
Generic Drug Product Information & Patent Information - Daily
|
|
Orange Book Data Updated Through April, 2013
|
|
Patent and Generic Drug Product Data Last Updated: May 24, 2013
|
-
